Cargando…
Central diabetes insipidus and pain medications – a risky combination
BACKGROUND: Central Diabetes Insipidus (CDI) results from decreased production of antidiuretic hormone (ADH) leading to an inability to concentrate urine. CDI is treated with desmopressin (DDAVP). Rarely reported in the literature, opioids and non-steroidal anti-inflammatories (NSAIDs) can induce hy...
Autores principales: | Pinto, Teresa E., Mokashi, Arati, Cummings, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207735/ https://www.ncbi.nlm.nih.gov/pubmed/34134784 http://dx.doi.org/10.1186/s40842-021-00124-9 |
Ejemplares similares
-
Central diabetes insipidus and burn trauma
por: Kopel, Jonathan, et al.
Publicado: (2022) -
Idiopathic partial central diabetes insipidus
por: Fabre, Larissa, et al.
Publicado: (2023) -
Transient Central Diabetes Insipidus Occurring After Vasopressin Infusion
por: Cristiano, Elizabeth A., et al.
Publicado: (2021) -
Pregnancy complicated by central diabetes insipidus and oligohydramnios
por: Imaizumi, Karin, et al.
Publicado: (2021) -
Oxcarbazepine Therapy for Complete Central Diabetes Insipidus
por: Abdallah, Basmah, et al.
Publicado: (2018)